JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Derived and engineered immune cells, including T cells and NK cells, present exciting potential for use in cancer immunotherapies. Generation of functional T cells from hPSCs allows for potential off-the-shelf T cell therapies, while genetically engineered CAR T cells enable targeted immunotherapy treatments.
Explore our portfolio of products to support your T cell and NK cell workflows.
Items 1-10 of 11
Recombinant human TGF-beta 1 (TGF-β 1) protein containing 112 amino acids expressed in HEK293 cells for improved protein activity and proper post-translational modifications.